Search results
Results From The WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
Side effects are those of the underlying medications. [1] Common side effects include poor coordination, poor appetite, nausea, numbness, and feeling tired. [3] More severe side effects include liver problems. [3]
Extensively drug-resistant tuberculosis (XDR-TB) is a form of tuberculosis caused by bacteria that are resistant to some of the most effective anti-TB drugs.XDR-TB strains have arisen after the mismanagement of individuals with multidrug-resistant TB (MDR-TB).
The medical history includes obtaining the symptoms of pulmonary TB: productive, prolonged cough of three or more weeks, chest pain, and hemoptysis.Systemic symptoms include low grade remittent fever, chills, night sweats, appetite loss, weight loss, easy fatiguability, and production of sputum that starts out mucoid but changes to purulent. [1]
The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), formerly the National Center for HIV, STD, and TB Prevention (NCHSTP) is a part of the Centers for Disease Control and Prevention and is responsible for public health surveillance, prevention research, and programs to prevent and control human immunodeficiency virus (HIV) infection and acquired ...
4-tert-Butylcatechol (TBC) is an organic chemical compound which is a derivative of catechol. [1] TBC is available in the form of a solid crystal flake [2] and 85% solution in methanol [3] or water. [4]
A combination drug or a fixed-dose combination (FDC) is a medicine that includes two or more active ingredients combined in a single dosage form. [1] Terms like "combination drug" or "combination drug product" can be common shorthand for an FDC product (since most combination drug products are currently FDCs), although the latter is more precise if in fact referring to a mass-produced product ...
n/a Ensembl ENSG00000275954 n/a UniProt A6NER0 n/a RefSeq (mRNA) NM_032258 n/a RefSeq (protein) NP_115634 n/a Location (UCSC) Chr 17: 36.43 – 36.44 Mb n/a PubMed search n/a Wikidata View/Edit Human TBC1 domain family member 3E/3F is a protein that in humans is encoded by the TBC1D3F gene. This gene encodes a protein that is similar to TBC1 domain family, member 3. This protein contains a TBC ...